Latest News and Press Releases
Want to stay updated on the latest news?
-
CytoSorbents Announces Fourth Quarter and Full Year 2024 Earnings Release Date for March 6, 2025
-
CytoSorbents Strengthens Balance Sheet with Additional $1.6M in Aggregate Gross Proceeds from Shareholder Exercise of Series A Right Warrant
-
CytoSorbents Is Scheduling In-Person Investor Meetings During the JP Morgan Healthcare Conference from Jan 13-15, 2025 in San Francisco.
-
PRINCETON, N.J., Nov. 07, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
-
CytoSorbents regains compliance with Nasdaq minimum bid price requirement
-
CytoSorbents new modern website launch unifies corporate and product websites and highlights "Working to Save Lives Together"
-
CytoSorbents new modern website launch unifies corporate and product websites and highlights "Working to Save Lives Together"
-
$20 million credit facility provides CytoSorbents with important non-dilutive capital to support its regulatory and commercialization objectives
-
CytoSorbents Provides Update on STAR-T Trial and Final Independent DSMB Recommendation
-
CytoSorbents to Highlight Company Progress at Dawson James Small Cap Investor Growth Conference